Medical devices, healthcare technology and the business of care
510(k) clearance · K261229

SCENARIA View Phase 6.0

Fujifilm Corporation · Decision date Sep 18, 2026

MEDTECHLEDGER EXPLANATIONK261229

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision on September 18, 2026 for SCENARIA View Phase 6.0, submitted by Fujifilm Corporation under 510(k) number K261229. The application was received April 15, 2026, reviewed under regulation 892.1750 in the Radiology panel, with classification product code JAK for computed tomography X-ray systems. A SESE decision is a 510(k) clearance, not a premarket approval.

The reviewed material describes DLR Focus, a deep-learning-based noise-reduction component using convolutional processing from a trained model. The available conclusion states that phantom and clinical image testing showed noise reduction without image quality degradation relative to the conventional method. The source does not specify which system components or labeling changed in Phase 6.0, the full indications, or the detailed test results; those remain in the underlying FDA documents rather than this summary.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Radiology
Decision date
Sep 18, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K261229
Regulatory pathway
510(k) premarket notification
Product code
JAK
Decision code
SESE
Decision date
Sep 18, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: System, X-Ray, Tomography, Computed.

Product code
JAK
FDA device class
2

FDA decision timeline

  1. K261229 received

    Application receipt date recorded by FDA.

  2. K261229 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code JAK

Product / regulatory recordCompanyPathwayDecision dateSource
Coreline Soft Co., Ltd.510(k) clearanceOct 16, 2026FDA
CAS-One IRK261225
Cascination AG510(k) clearanceSep 29, 2026FDA
Samsung HME America, Inc., dba NeuroLogica Corp.510(k) clearanceSep 22, 2026FDA
Fujifilm Corporation510(k) clearanceSep 4, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Fujifilm Corporation

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Minato-Ku

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records